IDO1 and myeloid sarcoma: We have previously published that levels of mRNA for indoleamine 2,3-dioxygenase (IDO)1/2 and arginase (ARG)1/2 are increased in PBMCs from CIS/MS patients33 and might provide a sustained homeostatic mechanism to control MS-associated inflammation.